Bluedoor Private Wealth LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 6,236 shares of the conglomerate’s stock, valued at approximately $1,428,000.
Several other large investors have also recently made changes to their positions in the business. Enterprise Financial Services Corp raised its stake in shares of Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after acquiring an additional 46 shares in the last quarter. Kennebec Savings Bank increased its stake in shares of Danaher by 1.4% in the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock worth $766,000 after buying an additional 46 shares during the period. Revolve Wealth Partners LLC increased its stake in shares of Danaher by 2.6% in the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after buying an additional 47 shares during the period. High Note Wealth LLC increased its stake in shares of Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after buying an additional 47 shares during the period. Finally, First Command Advisory Services Inc. increased its stake in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after buying an additional 47 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.
Danaher Stock Up 0.5%
Shares of Danaher stock opened at $181.04 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The company’s fifty day simple moving average is $180.73 and its two-hundred day simple moving average is $204.27. The company has a market cap of $128.13 billion, a P/E ratio of 35.02, a PEG ratio of 2.30 and a beta of 0.81. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.
Analysts Set New Price Targets
DHR has been the topic of several analyst reports. DZ Bank initiated coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price on the stock. Guggenheim decreased their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. decreased their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. The Goldman Sachs Group decreased their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Finally, TD Cowen decreased their target price on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.
Get Our Latest Stock Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
